a

3S Corporation is one of India’s leading stockist, exporter & wholesaler for Anti-cancer drug & Oncology medicines. We even supply & export Sex Enhancement Drugs, Cardiac & Anti Diabetic Medicines. We are a registered wholesaler & exporter for pharmaceutical products licensed by our FDA and Drug Controller in India. Our license number are 20-B/MZ6-23015 & 21-B/ MZ6-23016.

+(91)-(22)-42643060

3scorp.india@gmail.com
Andheri East, Mumbai - 400099, India.

DISCLAIMER

All the pharmaceutical products we offer are prescription drugs and should be used/taken under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. We are not an online pharmacy . We do not recommend any drug or give medical advice. We only express opinions and provide information. Whether a medication is right for you is a decision between you and the prescribing doctor. Kindly seek medical advice from a registered doctor 0r hospital/Institution before taking any of these medicines.

Monday - Saturday

10.00 - 19.00

+(91)-(22)-42643060

3scorp.india@gmail.com

Andheri East

Mumbai – 400099, India.

Edaravone Injection 30 mg

  •  neurotrophic drug
Category:

Description

Edaravone  Injection 30 mg is a neurotrophic drug, is prescribed to alleviate the neurological symptoms due to acute cerebral infarction and to improve routine activity and ability. Edaravone is also prescribed to treat functional disorders. Edaravone exerts cerebral protective activity by scavenging free radicals.As a free radical scavenger,Edaravone lowers N- acetyl aspartate (NAA) and reduce cerebral blood flow into the cerebral infarct areas.Edaravone  reduces cerebral edema and cerebral infarction and lowers lipid-peroxidation induced neuronal death and subsequent oxidative stress of endothelial cells of the brain.

3s corporation is Supplier,Exporter ,Wholesaler  for Edaravone  Injection 30 mg in India.

Additional Information

Consider administration of 30 mg of Edaravone injection reconstituted with normal saline, two times a day. The course of treatment should be less than 2 weeks. IV infusion of Edaravone should be considered within 24 hours of onset of symptoms.

Side Effects

Hepatic dysfunction, rash, Acute renal failure, nephritic syndrome, hepatitis, jaundice, thrombocytopenia, granulocytopenia, disseminated intravascular coagulation (DIC), acute lung injury, rhabdomyolysls, shock, anaphylactoid reaction etc.Incompatibilities : Edaravone injection should not be administered with infusion of anticonvulsant drugs like diazepam, phenytoin sodium, etc. and not be mixed with potassium canrenoate as the solution may becomes cloudy if administered together.

Pack Size